Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.

Standard

Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies. / Weber, Thomas; Ocheni, Sunday; Binder, Mascha; Theurich, Sebastian; Scheid, Christof; Schmid, Christoph; Müller, Lutz Peter; Christopeit, Maximilian; Bacher, Ulrike.

In: ACTA HAEMATOL-BASEL, Vol. 129, No. 3, 3, 2013, p. 135-136.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Weber, T, Ocheni, S, Binder, M, Theurich, S, Scheid, C, Schmid, C, Müller, LP, Christopeit, M & Bacher, U 2013, 'Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.', ACTA HAEMATOL-BASEL, vol. 129, no. 3, 3, pp. 135-136. https://doi.org/10.1159/000343422

APA

Weber, T., Ocheni, S., Binder, M., Theurich, S., Scheid, C., Schmid, C., Müller, L. P., Christopeit, M., & Bacher, U. (2013). Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies. ACTA HAEMATOL-BASEL, 129(3), 135-136. [3]. https://doi.org/10.1159/000343422

Vancouver

Bibtex

@article{da6cead263f146098be8b9051cee7c31,
title = "Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.",
keywords = "Adult, Humans, Male, Middle Aged, Remission Induction, Transplantation, Homologous, *Hematopoietic Stem Cell Transplantation, Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis/*therapy, Leukemia, Myeloid, Acute/diagnosis/*therapy, Lymphoma, B-Cell/diagnosis/*therapy, Multiple Myeloma/diagnosis/*therapy, Neoplasms, Second Primary/diagnosis/*therapy, Adult, Humans, Male, Middle Aged, Remission Induction, Transplantation, Homologous, *Hematopoietic Stem Cell Transplantation, Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis/*therapy, Leukemia, Myeloid, Acute/diagnosis/*therapy, Lymphoma, B-Cell/diagnosis/*therapy, Multiple Myeloma/diagnosis/*therapy, Neoplasms, Second Primary/diagnosis/*therapy",
author = "Thomas Weber and Sunday Ocheni and Mascha Binder and Sebastian Theurich and Christof Scheid and Christoph Schmid and M{\"u}ller, {Lutz Peter} and Maximilian Christopeit and Ulrike Bacher",
year = "2013",
doi = "10.1159/000343422",
language = "English",
volume = "129",
pages = "135--136",
journal = "ACTA HAEMATOL-BASEL",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "3",

}

RIS

TY - JOUR

T1 - Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.

AU - Weber, Thomas

AU - Ocheni, Sunday

AU - Binder, Mascha

AU - Theurich, Sebastian

AU - Scheid, Christof

AU - Schmid, Christoph

AU - Müller, Lutz Peter

AU - Christopeit, Maximilian

AU - Bacher, Ulrike

PY - 2013

Y1 - 2013

KW - Adult

KW - Humans

KW - Male

KW - Middle Aged

KW - Remission Induction

KW - Transplantation, Homologous

KW - Hematopoietic Stem Cell Transplantation

KW - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis/therapy

KW - Leukemia, Myeloid, Acute/diagnosis/therapy

KW - Lymphoma, B-Cell/diagnosis/therapy

KW - Multiple Myeloma/diagnosis/therapy

KW - Neoplasms, Second Primary/diagnosis/therapy

KW - Adult

KW - Humans

KW - Male

KW - Middle Aged

KW - Remission Induction

KW - Transplantation, Homologous

KW - Hematopoietic Stem Cell Transplantation

KW - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis/therapy

KW - Leukemia, Myeloid, Acute/diagnosis/therapy

KW - Lymphoma, B-Cell/diagnosis/therapy

KW - Multiple Myeloma/diagnosis/therapy

KW - Neoplasms, Second Primary/diagnosis/therapy

U2 - 10.1159/000343422

DO - 10.1159/000343422

M3 - SCORING: Journal article

C2 - 23207834

VL - 129

SP - 135

EP - 136

JO - ACTA HAEMATOL-BASEL

JF - ACTA HAEMATOL-BASEL

SN - 0001-5792

IS - 3

M1 - 3

ER -